David Abraham

19.6k total citations · 5 hit papers
221 papers, 15.1k citations indexed

About

David Abraham is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, David Abraham has authored 221 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 92 papers in Pathology and Forensic Medicine and 31 papers in Dermatology. Recurrent topics in David Abraham's work include Systemic Sclerosis and Related Diseases (88 papers), Connective Tissue Growth Factor Research (63 papers) and Dermatologic Treatments and Research (29 papers). David Abraham is often cited by papers focused on Systemic Sclerosis and Related Diseases (88 papers), Connective Tissue Growth Factor Research (63 papers) and Dermatologic Treatments and Research (29 papers). David Abraham collaborates with scholars based in United Kingdom, United States and Canada. David Abraham's co-authors include Andrew Leask, Shiwen Xu, John Varga, Christopher P. Denton, Carol M. Black, Alan Holmes, George Bou–Gharios, Markella Ponticos, Manuel Blum and Benjamin Maurer and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

David Abraham

211 papers receiving 14.7k citations

Hit Papers

TGF‐β signaling and the fibrotic response 2004 2026 2011 2018 2004 2007 2008 2006 2015 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Abraham United Kingdom 62 6.9k 4.5k 2.5k 1.9k 1.9k 221 15.1k
Anne Vincent‐Salomon France 70 5.5k 0.8× 3.0k 0.7× 2.2k 0.9× 2.3k 1.2× 921 0.5× 381 16.1k
Robert B. West United States 63 9.8k 1.4× 1.8k 0.4× 4.3k 1.7× 2.8k 1.5× 318 0.2× 185 20.2k
John M. Bennett United States 74 11.5k 1.7× 4.2k 0.9× 2.3k 0.9× 5.2k 2.7× 347 0.2× 396 41.1k
David J. Harrison United Kingdom 65 9.4k 1.4× 1.2k 0.3× 1.8k 0.7× 1.6k 0.9× 271 0.1× 482 17.6k
Stephen B. Fox Australia 84 14.2k 2.1× 2.8k 0.6× 4.7k 1.9× 3.1k 1.6× 656 0.3× 423 29.3k
Torsten O. Nielsen Canada 77 10.3k 1.5× 4.9k 1.1× 7.7k 3.0× 2.0k 1.0× 709 0.4× 241 31.1k
Tatsuhiko Tsunoda Japan 74 9.6k 1.4× 1.2k 0.3× 1.6k 0.6× 1.9k 1.0× 223 0.1× 277 17.6k
Jeffery L. Kutok United States 76 11.3k 1.6× 3.3k 0.7× 1.1k 0.4× 5.7k 3.0× 256 0.1× 192 21.4k
Gareth J. Morgan United Kingdom 87 15.0k 2.2× 3.4k 0.8× 1.1k 0.4× 4.6k 2.4× 274 0.1× 852 30.5k
Jonathan R. Pollack United States 57 14.9k 2.2× 2.6k 0.6× 3.9k 1.5× 1.1k 0.6× 347 0.2× 123 25.9k

Countries citing papers authored by David Abraham

Since Specialization
Citations

This map shows the geographic impact of David Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Abraham more than expected).

Fields of papers citing papers by David Abraham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Abraham. The network helps show where David Abraham may publish in the future.

Co-authorship network of co-authors of David Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of David Abraham. A scholar is included among the top collaborators of David Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Abraham. David Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tam, Angela, Korsa Khan, Shiwen Xu, et al.. (2025). Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma. Arthritis & Rheumatology. 77(7). 914–928.
2.
Papaioannou, Ioannis, Athina Dritsoula, Ping Kang, et al.. (2024). NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension. JCI Insight. 9(10).
3.
Saracino, Amanda, et al.. (2023). Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies. Archives of Dermatological Research. 315(7). 2035–2056. 2 indexed citations
4.
Mohamed‐Ali, Vidya, et al.. (2023). Relative Recovery of Non-Alcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Rats. Nutrients. 16(1). 115–115. 3 indexed citations
5.
Kanakis, Ioannis, Peter Milner, Andrew Leask, et al.. (2020). Post-traumatic osteoarthritis development is not modified by postnatal chondrocyte deletion of Ccn2. Disease Models & Mechanisms. 13(7). 5 indexed citations
6.
7.
Abraham, David, et al.. (2017). Consentimiento informado en Biobancos y Bases de Datos. SHILAP Revista de lepidopterología. 2 indexed citations
8.
Taher, Taher E., Jonas Byström, Voon H Ong, et al.. (2017). Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity. Clinical Reviews in Allergy & Immunology. 53(2). 237–264. 39 indexed citations
9.
Baker, Daryll, et al.. (2014). The Role of Erythropoietin in Skeletal Muscle Ischaemia In Vitro and In Vivo. European Journal of Vascular and Endovascular Surgery. 47(6). 694–695. 1 indexed citations
10.
11.
Nikitorowicz-Buniak, Joanna, Shiwen Xu, Andrew Leask, et al.. (2011). Thrombospondin 1 in hypoxia-conditioned media blocks the growth of human microvascular endothelial cells and is increased in systemic sclerosis tissues. PubMed. 4(1). 13–13. 18 indexed citations
12.
Holmes, Alan, Markella Ponticos, Shiwen Xu, Christopher P. Denton, & David Abraham. (2011). Elevated CCN2 expression in scleroderma: a putative role for the TGFβ accessory receptors TGFβRIII and endoglin. Journal of Cell Communication and Signaling. 5(3). 173–177. 12 indexed citations
13.
Hoyles, Rachel K., Emma Derrett‐Smith, Korsa Khan, et al.. (2010). An Essential Role for Resident Fibroblasts in Experimental Lung Fibrosis Is Defined by Lineage-Specific Deletion of High-Affinity Type II Transforming Growth Factor β Receptor. American Journal of Respiratory and Critical Care Medicine. 183(2). 249–261. 92 indexed citations
14.
Leask, Andrew, Shiwen Xu, Korsa Khan, et al.. (2008). Loss of protein kinase Cϵ results in impaired cutaneous wound closure and myofibroblast function. Journal of Cell Science. 121(20). 3459–3467. 26 indexed citations
15.
Winter, Patricia de, Patricia Leoni, & David Abraham. (2008). Connective tissue growth factor: Structure–function relationships of a mosaic, multifunctional protein. Growth Factors. 26(2). 80–91. 116 indexed citations
16.
Xu, Shiwen, Laura Kennedy, Daphne Pala, et al.. (2006). CCN2 Is Necessary for Adhesive Responses to Transforming Growth Factor-β1 in Embryonic Fibroblasts. Journal of Biological Chemistry. 281(16). 10715–10726. 136 indexed citations
17.
Abraham, David, Robert W. Irving, & David F. Manlove. (2006). Two algorithms for the Student-Project Allocation problem. Journal of Discrete Algorithms. 5(1). 73–90. 73 indexed citations
18.
Chen, Yunliang, Shiwen Xu, Laura Kennedy, et al.. (2005). Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-β/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK. American Journal Of Pathology. 167(6). 1699–1711. 119 indexed citations
19.
Abraham, David, et al.. (2001). The logic tutor.. 184. 1 indexed citations
20.
Stratton, Richard, Shiwen Xu, Giorgia Martini, et al.. (2001). Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. Journal of Clinical Investigation. 108(2). 241–250. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026